rs7129781
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_024514.5(CYP2R1):c.225+1110A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0836 in 985,164 control chromosomes in the GnomAD database, including 3,872 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as association (no stars).
Frequency
Genomes: 𝑓 0.10 ( 1041 hom., cov: 31)
Exomes 𝑓: 0.080 ( 2831 hom. )
Consequence
CYP2R1
NM_024514.5 intron
NM_024514.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.338
Publications
15 publications found
Genes affected
CYP2R1 (HGNC:20580): (cytochrome P450 family 2 subfamily R member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This enzyme is a microsomal vitamin D hydroxylase that converts vitamin D into the active ligand for the vitamin D receptor. A mutation in this gene has been associated with selective 25-hydroxyvitamin D deficiency. [provided by RefSeq, Jul 2008]
PDE3B (HGNC:8779): (phosphodiesterase 3B) Enables 3',5'-cyclic-nucleotide phosphodiesterase activity. Involved in negative regulation of angiogenesis; negative regulation of cell adhesion; and negative regulation of lipid catabolic process. Located in membrane. Part of guanyl-nucleotide exchange factor complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.182 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.102 AC: 15566AN: 151960Hom.: 1041 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
15566
AN:
151960
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0802 AC: 66777AN: 833086Hom.: 2831 Cov.: 29 AF XY: 0.0797 AC XY: 30647AN XY: 384712 show subpopulations
GnomAD4 exome
AF:
AC:
66777
AN:
833086
Hom.:
Cov.:
29
AF XY:
AC XY:
30647
AN XY:
384712
show subpopulations
African (AFR)
AF:
AC:
3051
AN:
15782
American (AMR)
AF:
AC:
50
AN:
984
Ashkenazi Jewish (ASJ)
AF:
AC:
317
AN:
5152
East Asian (EAS)
AF:
AC:
556
AN:
3630
South Asian (SAS)
AF:
AC:
1258
AN:
16462
European-Finnish (FIN)
AF:
AC:
16
AN:
276
Middle Eastern (MID)
AF:
AC:
114
AN:
1620
European-Non Finnish (NFE)
AF:
AC:
59144
AN:
761880
Other (OTH)
AF:
AC:
2271
AN:
27300
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
3041
6083
9124
12166
15207
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
3078
6156
9234
12312
15390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.103 AC: 15592AN: 152078Hom.: 1041 Cov.: 31 AF XY: 0.101 AC XY: 7487AN XY: 74360 show subpopulations
GnomAD4 genome
AF:
AC:
15592
AN:
152078
Hom.:
Cov.:
31
AF XY:
AC XY:
7487
AN XY:
74360
show subpopulations
African (AFR)
AF:
AC:
7675
AN:
41462
American (AMR)
AF:
AC:
995
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
AC:
175
AN:
3468
East Asian (EAS)
AF:
AC:
831
AN:
5166
South Asian (SAS)
AF:
AC:
373
AN:
4816
European-Finnish (FIN)
AF:
AC:
452
AN:
10602
Middle Eastern (MID)
AF:
AC:
32
AN:
294
European-Non Finnish (NFE)
AF:
AC:
4752
AN:
67978
Other (OTH)
AF:
AC:
218
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
688
1376
2063
2751
3439
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
170
340
510
680
850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
463
AN:
3478
ClinVar
Significance: association
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Pulmonary disease, chronic obstructive, susceptibility to Other:1
Jul 05, 2022
HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas
Significance:association
Review Status:no assertion criteria provided
Collection Method:research
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.